期刊文献+

CKMB在心肌梗死患者的诊断限选择 被引量:1

Selection of Diagnostic Cutoff Value of CKMB in the Patients with Suspicious Myocardial Infarction
下载PDF
导出
摘要 目的比较不同CKMB诊断限对心肌梗死(MI)诊断所造成的影响。方法测定927例心肌梗塞可疑病例入院24小时内,血中cTnI和CKMB水平。分别以两倍参考范围上限值、健康人群第99百分位数、健康人群第97.5百分位数、正常参考范围上限、ROC曲线确定的最佳截断点作为Cutoff值,比较CKMB的阳性率、诊断效率、与cTnI的符合程度。结果应用不同诊断限时,CKMB阳性率从2.7%到8.3%;cTnI(+)/CKMB(+)例数从18例(1.9%)到30例(3.2%);cTnI(-)/CKMB(-)例数从842例(90.8%)到802例(86.5%)。cTnI(+)/CKMB(+)病例中的cTnI的浓度要明显高于cTnI(+)/CKMB(-)病例中的浓度。结论采用较低的诊断限(ROC)时,CKMB阳性率增加,和cTnI的符合程度较好,有较高的诊断效率。 Objective To compare different diagnostic outcome of suspicious myocardial infarction (MI) when applying different cutoff value of Creatine Kinase MB (CKMB). Materials We measured plasma levels of cardiac troponin (cTNI) and CKMB of 927 consecutive patients with suspected MI in 24h after admission. The positive rate, diagnostic efficiency as well as the coincidence rate of cTNI and CKMB were compared based on different CKMB cutoff value, including twice the ULR ( 〉 50U/L), 99^th percentile, 97.5th percentile, ULR and optimum cutoff value determined by ROC curve ( 〉 21U/L). Results The positive rate of CKMB ranged from 2.7% when using twice URL as cutoff value to 8.3% when using the ROC recommended cutoff value; the positive coincidence rate of cTNI and CKMB ranged from 1.9% (18) to 3.2% (30); the negative coincidence rate of cTNI and CKMB ranged from 90.8% (842) to 86.5% (802). The level of plasma cTNI in cTNI ( + ) /CKMB ( + ) cases was obviously higher than that in cTNI ( + ) /CKMB (-) cases. Conclusions Applying lower diagnostic cutoff value of CKMB as recommended by ROC curve can notably increase the rates of CKMB ( + ) cases, the concordance with cTNI and diagnostic efficiency.
出处 《浙江预防医学》 2006年第8期10-12,共3页 Zhejiang Journal of Preventive Medicine
关键词 心肌梗死 肌酸磷酸激酶同工酶(CKMB) 心肌肌钙蛋白Ⅰ(cTnⅠ) 诊断 Myocardial infarction CKMB cTNI Diagnosis
  • 相关文献

参考文献8

  • 1Nomenclature and criteria for diagnosis of ischemic heart case:report of the joint International society and federation of cardioglogy/World Health Organization task force on standization of clinical nomemclature[J].Circulation,1979,59:607~609.
  • 2杨振华.心肌梗死的诊断标准是否要修改?[J].中华医学杂志,2001,81(7):387-388. 被引量:11
  • 3张克坚,杨振华.应用ROC曲线图评价检验项目的临床准确性[J].临床检验信息导报,1998,5(4):105-112. 被引量:20
  • 4Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J].J Am Coll Cardiol,2000,36:959~969.
  • 5Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction:executive summary and recommendations.A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients with Unstable Angina)[J].Circulation,2000,102,1193~1209.
  • 6Jaffe AS,Ravkilde J,Roberts R,et al.It's time for a change to a troponin standard[J].Circulation,2000,102:1216~ 1220.
  • 7Apple FS,Johari V,Hoybook KJ,et al.Operationalizing cardiac troponin Ⅰ testing along ESC/ACC consensus guidelines for defining myocardial infarction[J].Clin Chim Acta,2003,331:165 ~ 166.
  • 8Joseph C.Lin,Fred S.Apple,MaryAnn M.Murakami,et al.Rates of Positive Cardiac Troponin Ⅰ and Creatine Kinase MB Mass among Patients Hospitalized for Suspected Acute Coronary Syndromes[J].Clinical Chemistry,2004,50:2,333~338.

共引文献28

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部